Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
Clinical trial NCT03294577 · UNKNOWN
Trial details
- NCT number
- NCT03294577
- Sponsor
- BeyondSpring Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2020-09-25
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.